Telomir Pharmaceuticals Inc
TELO
Get informed when a big investor buys or sells
+ FollowMarket Cap$44.7M
Close$
$0.23
81.9% downside
Current Fair Value
81.9% downsideOvervalued by 81.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $44.70 Million |
|---|---|
| Enterprise Value | $39.13 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.33 |
| Beta | -0.21 |
| Outstanding Shares | 34,380,971 |
Return
| Return on Equity | -185.89% |
|---|---|
| Return on Assets | -159.33% |
| Return on Invested Capital | -188.31% |
Valuation & Multiples
| P/E Ratio | -4.85 |
|---|---|
| PEG | 8.88 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.19 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.52%▼ 0.85% |
|---|---|
| Total Invested | $2.91M▼ 4.18% |
| Investors Holding | 27▼ 6.00% |
ESG Score
No data